Eiko LifeSciences Ltd. / Fundamentals
Income statement
- Net revenue
€3.68M - Cost of goods sold
€3.19M - Gross profit
€488.26K - SG&A expenses
€12.74K - R&D expenses
€0.00 - EBITDA
€386.63K - D&A
€71.97K - EBIT
€151.39K - Interest expenses
€15.50K - EBT
€299.16K - Tax expenses
€72.84K - Net income
€205.52K
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€224.89K - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€1.15M - Cash and short-term investments
€1.15M - Total receivables
€1.05M - Inventory
€563.66K - Other current assets
€442.70K - Total current assets
€3.21M - Property, plant & equipment
€2.26M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€698.28K - Other non-current assets
€288.09K - Total non-current assets
€3.24M - Total assets
€6.45M - Accounts payable
€323.54K - Short-term debt
€73.70K - Other current liabilities
€214.31K - Total current liabilities
€611.55K - Long-term debt
€196.02K - Deferred tax liabilities
€80.16K - Other non-current liabilities
€0.00 - Total non-current liabilities
€276.18K - Total liabilities
€887.73K - Common stock
€1.34M - Retained earnings
€0.00 - Other equity
€4.20M - Total equity
€5.56M - Total liabilities and shareholders' equity
€6.45M
Company information
- Market capitalization
€6.92M - Employees
3 - Enterprise Value
€679.41M
Company ratios
- Gross margin
-
13.3% - EBITDA margin
-
10.5% - EBIT margin
-
4.1% - EBT margin
-
8.1% - Net margin
-
5.6% - ROE
-
3.7% - ROA
-
3.2% - Asset turnover
-
57.0% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
89.5% - Net sales per employee
-
€1.23M - Net income per employee
-
€68.51K